Clinical Trial Provides Hope for Multiple Myeloma Patients
Findings from two large, international clinical trials show unparalleled survival for patients with multiple myeloma, a blood cancer of the blood-making cells of the bone marrow.
The findings demonstrate that with Revlimid, an oral cancer drug, all measures of myeloma showed significant improvement in patients where previous treatments had failed.
Rush University Medical Center took [...]